Beyond β-Blockade: ACE Inhibitors Reduce Non-Cardiac Mortality in High Killip Grade AMI Patients.

Simei SunXiongyi HanLiyan BaiMyung Ho JeongCheng Jin

Published in: Journal of cardiovascular pharmacology and therapeutics (2024)

Our results suggest that BB + ACEI treatment is more beneficial than BB + ARB for high Killip grade AMI patients. Additionally, the BB + ACEI group has a superior preventative effect on mortality compared to the BB + ARB group.

Keyphrases

end stage renal disease
growth factor
chronic kidney disease
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
type diabetes
left ventricular
heart failure
recombinant human
atrial fibrillation